Daphnetin Capsule for Mild Cognitive Issues From Blood Vessels
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a capsule called daphnetin for people with mild thinking and memory problems linked to blood vessel health. The goal is to see if it helps improve or slow down these changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 80 years old.
- You have had problems with memory or thinking for at least 3 months.
- You do not have dementia and have not been diagnosed with Alzheimer's or similar conditions.
- You have a reliable family member or friend who can help you during the study.
- You have not had a stroke in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the herbal capsule Tongxinluo can improve memory and thinking in people with small vessel disease, a condition that affects blood flow in the brain. Participants will receive either the capsule or a placebo (a pill with no active ingredient) for a period of time to see if it helps.
This Phase 2 study tests whether the cholesterol medicine atorvastatin can improve how well blood vessels in the brain respond in people with mild cognitive impairment (MCI). It may help brain circulation and possibly slow thinking and memory problems.
This trial studies EGb 761 to see if it can improve symptoms in people with mild cognitive impairment (early memory/thinking changes) who also have signs of brain blood vessel disease. It may help by targeting the brain changes seen on scans.
This study tests whether a special drink containing medium-chain triglycerides (MCTs, a type of fat) and B vitamins can help support memory and thinking in older adults with mild cognitive impairment (MCI). You would take the drink daily for 18 months and have regular check-ins including memory tests.
This trial tests whether a natural plant compound can help support memory and thinking in people at higher risk for Alzheimer's disease. You may qualify if you are over 50, overweight, eat a typical Western diet, and have a family history of Alzheimer's.
This trial tests a Chinese herbal capsule called Fufang Congrong Yizhi Capsule (FCYC) to see if it can help with memory and thinking problems that start after a bleeding stroke. It is for people who have had robot-assisted surgery for their stroke and also fit a specific pattern in traditional Chinese medicine.
Hear when a new Cerebrovascular Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.